CLOV vs. NU
CLOV (Clover Health Investments, Corp.) and NU (Nu Holdings Ltd.) are both stocks. CLOV operates in Healthcare Plans (Healthcare), while NU operates in Banks - Diversified (Financial Services). Over the past 3 years, CLOV returned 78.71%/yr vs 18.53%/yr for NU. At a 0.32 correlation, their price movements are largely independent.
Performance
CLOV vs. NU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLOV achieves a 115.32% return, which is significantly higher than NU's -24.79% return.
CLOV
- 1D
- -1.56%
- 1M
- 42.54%
- YTD
- 115.32%
- 6M
- 100.79%
- 1Y
- 78.80%
- 3Y*
- 78.71%
- 5Y*
- -18.17%
- 10Y*
- —
NU
- 1D
- -1.56%
- 1M
- -1.10%
- YTD
- -24.79%
- 6M
- -24.88%
- 1Y
- 2.03%
- 3Y*
- 18.53%
- 5Y*
- —
- 10Y*
- —
CLOV vs. NU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 115.32% | -25.40% | 230.85% | 2.43% | -75.01% | -20.00% |
NU Nu Holdings Ltd. | -24.79% | 61.58% | 24.37% | 104.67% | -56.61% | -16.62% |
Correlation
The correlation between CLOV and NU is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Dec 9, 2021 | 0.32 |
Fundamentals
CLOV:
$2.64B
NU:
$61.82B
CLOV:
-$0.11
NU:
$0.65
CLOV:
1.18
NU:
3.52
CLOV:
7.78
NU:
4.91
CLOV:
$2.21B
NU:
$17.54B
CLOV:
$939.14M
NU:
$7.67B
CLOV:
-$55.21M
NU:
$4.14B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLOV vs. NU — Risk / Return Rank
CLOV
NU
CLOV vs. NU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Nu Holdings Ltd. (NU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLOV | NU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.06 | ||
| Sortino ratioReturn per unit of downside risk | +1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.04 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.43 | 0.05 | +1.37 |
| Martin ratioReturn relative to average drawdown | 2.60 | 0.13 | +2.47 |
Loading charts...
Drawdowns
CLOV vs. NU - Drawdown Comparison
The maximum CLOV drawdown since its inception was -97.19%, which is greater than NU's maximum drawdown of -72.07%. Use the drawdown chart below to compare losses from any high point for CLOV and NU.
Loading charts...
Drawdown Indicators
| CLOV | NU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.19% | -72.07% | -25.12% |
Max Drawdown (1Y)Largest decline over 1 year | -55.50% | -38.17% | -17.33% |
Max Drawdown (3Y)Largest decline over 3 years | -64.73% | -39.58% | -25.15% |
Max Drawdown (5Y)Largest decline over 5 years | -95.35% | — | — |
Current DrawdownCurrent decline from peak | -77.16% | -32.89% | -44.27% |
Average DrawdownAverage peak-to-trough decline | -76.59% | -29.78% | -46.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.42% | 16.15% | +14.27% |
Volatility
CLOV vs. NU - Volatility Comparison
Clover Health Investments, Corp. (CLOV) has a higher volatility of 26.10% compared to Nu Holdings Ltd. (NU) at 13.14%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than NU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLOV | NU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.10% | 13.14% | +12.96% |
Volatility (6M)Calculated over the trailing 6-month period | 43.24% | 28.85% | +14.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.33% | 38.18% | +33.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.99% | 58.36% | +18.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.67% | 58.36% | +27.31% |
Dividends
CLOV vs. NU - Dividend Comparison
Neither CLOV nor NU has paid dividends to shareholders.
Financials
CLOV vs. NU - Financials Comparison
This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Nu Holdings Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLOV vs. NU - Profitability Comparison
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.
NU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nu Holdings Ltd. reported a gross profit of 2.00B and revenue of 4.98B. Therefore, the gross margin over that period was 40.2%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.
NU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nu Holdings Ltd. reported an operating income of 954.31M and revenue of 4.98B, resulting in an operating margin of 19.2%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.
NU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nu Holdings Ltd. reported a net income of 872.06M and revenue of 4.98B, resulting in a net margin of 17.5%.
Frequently Asked Questions
CLOV and NU have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLOV has higher volatility (26.10%) compared to NU (13.14%). In terms of maximum drawdown, CLOV dropped -97.19% vs NU's -72.07%.
CLOV currently has the higher Sharpe Ratio (1.12 vs 0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLOV and NU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer